Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Novo Nordisk Denmark A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   3.2% 2.2% 1.2% 1.2% 1.3% 1.5% 7.8% 7.8%   Credit score (0-100)   57 68 82 81 80 74 31 31   Credit rating   BBB BBB A A A A BB BB   Credit limit (mDKK)   0.0 0.0 2.4 2.9 2.3 0.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   342 364 330 374 510 2,017 2,017 2,017   Gross profit   119 135 276 299 333 473 0.0 0.0   EBITDA   6.3 9.0 37.4 40.1 52.0 111 0.0 0.0   EBIT   6.2 8.8 28.2 30.2 42.6 101 0.0 0.0   Pre-tax profit (PTP)   6.2 8.3 28.0 28.6 44.0 107.9 0.0 0.0   Net earnings   4.2 5.3 21.3 21.4 33.5 82.0 0.0 0.0   Pre-tax profit without non-rec. items   6.2 8.3 28.0 28.6 44.0 108 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1.5 1.3 21.2 15.7 30.0 39.2 0.0 0.0   Shareholders equity total   10.1 15.3 36.6 37.0 49.1 97.6 15.1 15.1   Interest-bearing liabilities   30.4 37.3 373 59.0 203 830 0.0 0.0   Balance sheet total (assets)   130 150 585 283 447 1,184 15.1 15.1   Net Debt   1.0 -99.9 373 59.0 203 830 -15.1 -15.1     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   342 364 330 374 510 2,017 2,017 2,017   Net sales growth   7.7% 6.4% -9.3% 13.3% 36.4% 295.6% 0.0% 0.0%   Gross profit   119 135 276 299 333 473 0.0 0.0   Gross profit growth   6.8% 13.1% 104.7% 8.2% 11.5% 42.1% -100.0% 0.0%   Employees   0 0 152 176 200 236 0 0   Employee growth %   0.0% 0.0% 0.0% 15.8% 13.6% 18.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   130 150 585 283 447 1,184 15 15   Balance sheet change%   4.2% 15.0% 291.0% -51.5% 57.6% 165.0% -98.7% 0.0%   Added value   6.3 9.0 37.4 40.1 52.5 110.8 0.0 0.0   Added value %   1.9% 2.5% 11.3% 10.7% 10.3% 5.5% 0.0% 0.0%   Investments   -0 -0 11 -15 5 -1 -39 0   Net sales trend   1.0 2.0 -1.0 1.0 2.0 3.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   1.9% 2.5% 11.3% 10.7% 10.2% 5.5% 0.0% 0.0%   EBIT %   1.8% 2.4% 8.5% 8.1% 8.4% 5.0% 0.0% 0.0%   EBIT to gross profit (%)   5.2% 6.5% 10.2% 10.1% 12.8% 21.3% 0.0% 0.0%   Net Earnings %   1.2% 1.4% 6.4% 5.7% 6.6% 4.1% 0.0% 0.0%   Profit before depreciation and extraordinary items %   1.3% 1.5% 9.2% 8.4% 8.4% 4.5% 0.0% 0.0%   Pre tax profit less extraordinaries %   1.8% 2.3% 8.5% 7.7% 8.6% 5.3% 0.0% 0.0%   ROA %   5.2% 6.6% 7.9% 7.1% 12.3% 13.6% 0.0% 0.0%   ROI %   16.0% 19.3% 11.9% 10.7% 20.0% 16.9% 0.0% 0.0%   ROE %   52.8% 41.3% 81.9% 58.2% 77.9% 111.7% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   7.8% 10.3% 6.3% 13.1% 11.0% 8.2% 100.0% 100.0%   Relative indebtedness %   34.8% 36.5% 161.6% 55.8% 70.5% 51.6% 0.0% 0.0%   Relative net indebtedness %   26.2% -1.1% 161.6% 55.8% 70.5% 51.6% -0.8% -0.8%   Net int. bear. debt to EBITDA, %   15.5% -1,111.2% 997.4% 147.3% 390.3% 749.5% 0.0% 0.0%   Gearing %   301.6% 243.0% 1,019.6% 159.5% 413.0% 850.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.0% 2.7% 0.5% 1.0% 0.7% 0.5% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.1 1.1 1.3 1.2 1.1 0.0 0.0   Current Ratio   1.1 1.1 1.1 1.3 1.2 1.1 0.0 0.0   Cash and cash equivalent   29.4 137.2 0.0 0.0 0.0 0.0 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.1 0.3 56.2 49.6 69.9 69.3 0.0 0.0   Trade creditors turnover (days)   24.3 23.5 17.0 13.9 11.8 5.8 0.0 0.0   Current assets / Net sales %   37.6% 40.7% 170.8% 71.6% 81.7% 56.7% 0.8% 0.8%   Net working capital   9.6 15.3 39.7 63.9 77.9 133.2 0.0 0.0   Net working capital %   2.8% 4.2% 12.0% 17.1% 15.3% 6.6% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 2 2 3 9 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0